Last updated: 2026-10-12 09:22:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Illumina Inc. (ILMN) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $278,44, with a market capitalisation of $42,00B and a P/E ratio of 50,91. Over the past 52 weeks, its price has ranged from $88,00 to $309,35. This page covers its latest market performance, valuation, price trends and company information.
$42,00B | |
$278,60 | |
$555,77 | |
$1,94 | |
$278,17 | |
719,00 | |
2,72M | |
50,91 | |
$309,35 | |
$88,00 | |
-- | |
-- |
Illumina Inc. (ILMN) is trading at $278,44 in pre-market trading as of 2026-10-12 09:15:00, up 0,10% ($0,27) from the previous close of $278,17
Pre-market trading shows how investors are pricing ILMN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Illumina Inc. (ILMN) moved from $265,72 to $278,44, representing a gain of 4,79% ($12,72).
The stock traded between $254,00 and $309,35 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 3,06 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 86,0%
ILMN is currently trading at $278,44, placing it 86,0% of the way from its 52-week low of $88,00 to its 52-week high of $309,35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 8650 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Illumina Inc. (ILMN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.